Algorae Pharmaceuticals Ltd (LHI0)

Currency in EUR
0.0015
0.0000(0.00%)
Delayed Data·
LHI0 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LHI0 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00150.0015
52 wk Range
0.00050.0055
Key Statistics
Bid/Ask
0.0015 / 0.0055
Prev. Close
0.0015
Open
0.0015
Day's Range
0.0015-0.0015
52 wk Range
0.0005-0.0055
Volume
-
Average Volume (3m)
5.9K
1-Year Change
50%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LHI0 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Algorae Pharmaceuticals Ltd Company Profile

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer’s disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson’s disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the University of New South Wales, an artificial intelligence platform for biopharmaceutical prediction of both fixed dose combination drug targets and repurposed drug targets agnostic to medical indication. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.

Compare LHI0 to Peers and Sector

Metrics to compare
LHI0
Peers
Sector
Relationship
P/E Ratio
−6.5x−3.9x−0.5x
PEG Ratio
−0.14−0.030.00
Price/Book
3.5x3.1x2.6x
Price / LTM Sales
67.4x19.2x3.2x
Upside (Analyst Target)
-309.9%42.0%
Fair Value Upside
Unlock−1.8%6.6%Unlock

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

LHI0 Income Statement

FAQ

What Stock Exchange Does Algorae Pharmaceuticals Ltd Trade On?

Algorae Pharmaceuticals Ltd is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Algorae Pharmaceuticals Ltd?

The stock symbol for Algorae Pharmaceuticals Ltd is "LHI0."

What Is the Algorae Pharmaceuticals Ltd Market Cap?

As of today, Algorae Pharmaceuticals Ltd market cap is 5.71M.

What Is Algorae Pharmaceuticals Ltd's Earnings Per Share (TTM)?

The Algorae Pharmaceuticals Ltd EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is LHI0 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Algorae Pharmaceuticals Ltd Stock Split?

Algorae Pharmaceuticals Ltd has split 2 times.

How Many Employees Does Algorae Pharmaceuticals Ltd Have?

Algorae Pharmaceuticals Ltd has 48 employees.

What is the current trading status of Algorae Pharmaceuticals Ltd (LHI0)?

As of 30 Jul 2025, Algorae Pharmaceuticals Ltd (LHI0) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.